Newsletters (Portuguese only)

 

NL - 2021 Editions	Highlights
Edition 12	2021 Year Review
Edition 11	Osteoporosis / Fragility Fractures Protocol
Edition 10	Reuma.pt course – from theory to practice
Edition 9	Reuma.pt at CPR 2021
Edition 8	Reuma.pt course – from theory to practice
Edition 7	Platform for projects submission
Edition 6	26000 patients
Edition 5	Tickets
Edition 4	Access to the patient's area
Edition 3	Automated informed consent
Edition 2	13 years of Reuma.pt
Edition 1	COVID-19 vaccination

 

NL - 2020 Editions	Highlights
Edition 12	Season’s Greetings
Edition 11	Acknowledgment
Edition 10	COVID-19 patients at Reuma.pt
Edition 9	End of mandate, accounting period
Edition 8	24000 patients
Edition 7	Online questionnaires for patients & Biosimilar drugs
Edition 6	Musculoskeletal ultrasound
Edition 5	39 COVID-19 patients at Reuma.pt
Edition 4	COVID-19 patients at Reuma.pt
Edition 3	We stay at home, but connected and working
Edition 2	12 years of Reuma.pt
Edition 1	Total at the end of 2019

 

NL - 2019 Editions	Highlights
Edition 12	Season’s Greetings
Edition 11	PRO Rheuma initiative
Edition 10	22000 patients
Edition 9	Biosimilar drugs
Edition 8	Follow-up Losses
Edition 7	Projects and Publications
Edition 6	21000 patients
Edition 5	Informed (Re)Consent
Edition 4	New Protocol MYOSITIS
Edition 3	Osteoarthritis protocol
Edition 2	11 years of Reuma.pt
Edition 1	Total at the end of 2018

 

NL - 2018 Editions	Highlights
Edition 12	20000 patients
Edition 11	Rheumatoid arthritis protocol
Edition 10	Drugs and adverse events
Edition 9	Access to the patient's area
Edition 8	Scleroderma
Edition 7	Prescription and dispensing of biological drugs
Edition 6	19000 patients
Edition 5	General Data Protection Regulation
Edition 4	End of mandate, accounting period
Edition 3	Biosimilar drugs
Edition 2	10 years of Reuma.pt
Edition 1	Total at the end of 2017

 

NL - 2017 Editions	Highlights
Edition 12	Use of Reuma.pt by patients
Edition 11	18000 patients
Edition 10	Vasculitis
Edition 9	Adverse events associated with biologic drugs
Edition 8	Dates of diagnosis and disease onset
Edition 7	Loss to follow-up
Edition 6	RAID
Edition 5	Geographical distribution of Reuma.pt patients
Edition 4	Early arthritis
Edition 3	Biological drugs
Edition 2	9 years of Reuma.pt
Edition 1	Total at the end of 2016

 

NL - 2016 Editions	Highlights
Edition 12	Clinical trials: Biomarkers in ankylosing spondylitis
Edition 11	1st Edition of Janssen Innovation Award
Edition 10	End of mandate, accounting period
Edition 9	Patients adherence to Reuma.pt
Edition 8	Data extraction
Edition 7	Sjögren´s syndrome
Edition 6	15000 patients
Edition 5	Hepatitis B and C serology tests
Edition 4	Patient's self assessment forms
Edition 3	Biological drugs
Edition 2	Biosimilar drugs
Edition 1	Security of the biological therapies

 

NL - 2015 Editions	Highlights
Edition 12	Total at the end of 2015
Edition 11	Scientific articles
Edition 10	100 000 visits
Edition 9	Scleroderma
Edition 8	Active TB disease
Edition 7	Clinical trial for patients with gonarthrosis
Edition 6	Lab analysis
Edition 5	Pediatric rheumatology
Edition 4	Frequently Asked Questions
Edition 3	Clinical trials: GO-DACT
Edition 2	Osteoarthritis
Edition 1	Biological treatments

 

NL - 2014 Editions	Highlights
Edition 12	Total at the end of 2014
Edition 11	Visits at the start of biological treatments
Edition 10	Vasculitis
Edition 9	End of mandate, accounting period
Edition 8	Apps on the Reuma.pt website
Edition 7	Selection of patients through filters
Edition 6	Analysis of data inconsistencies
Edition 5	Reuma.pt outputs
Edition 4	Adverse drug reactions
Edition 3	Sharing patients between centres
Edition 2	6 years of Reuma.pt
Edition 1	Autoinflammatory syndromes

 

NL - 2013 Editions	Highlights
Edition 4	10.000 patients and 60.000 visits
Edition 3	"Hospital do Futuro 2012/2013" Awards
Edition 2	Patient's self assessment forms
Edition 1	Statistical reports, a new tool at your disposal in Reuma.pt

 

NL - 2012 Editions	Highlights
Edition 3	The Reuma.pt is already over 6000 patients, having grown 50% in just over a year. The number of registered visits is about 38.000
Edition 2	Inconsistencies report, a new tool available to increase data quality
Edition 1	Reuma.pt web version - available from April 16

 

NL - 2011 Editions	Highlights
Edition 6	The Reuma.pt has as total of 4749 patients, 1500 treated with biological agents!
Edition 5	It is essential to fill in DAS28 components at every visit of patients with RA
Edition 4	The Reuma.pt grew 25% in last half year, having now almost 4000 patients!!
Edition 3	It is essential to introduce the data for the visit before the beginning of treatment with biological agent
Edition 2	It is essential to enter data currently missing in Reuma.pt!
Edition 1	The Reuma.pt already includes more than 15000 visits, > 4 visits / patient on average!

 

NL - 2010 Editions	Highlights
Edition 1	The Reuma.pt already surpassed the threshold of 3000 patients!!